Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,028 | 1,367 | 1,397 | 1,390 | 1,059 |
| Gross Profit | 1,028 | 1,367 | 1,397 | 1,390 | 1,059 |
| Operating Expenses | 8,147 | 7,109 | 5,879 | 2,928 | 4,595 |
| Operating Income | -7,119 | -5,742 | -4,482 | -1,538 | -3,536 |
| Interest Expense | 17 | 0 | 0 | 0 | 548 |
| Other Income | 190 | 29 | 59 | 6,689 | -13,317 |
| Pre-tax Income | -6,946 | -5,713 | -4,423 | 5,151 | -17,401 |
| Net Income Continuous | -6,946 | -5,713 | -4,423 | 5,151 | -17,401 |
| Net Income | $-6,946 | $-5,713 | $-4,423 | $5,151 | $-17,401 |
| EPS Basic Total Ops | -1.05 | 23.11 | -1.00 | 0.50 | -29.86 |
| EPS Basic Continuous Ops | -1.05 | 21.02 | -1.03 | 2.66 | -29.85 |
| EPS Diluted Total Ops | -1.05 | 23.86 | -1.00 | -0.25 | -29.86 |
| EPS Diluted Continuous Ops | -1.05 | 23.07 | -1.03 | 0.62 | -29.85 |
| EPS Diluted Before Non-Recurring Items | -1.05 | 0.00 | -1.00 | -0.25 | -14.00 |
| EBITDA(a) | $-7,023 | $-5,597 | $-4,405 | $-1,461 | $-3,390 |